Kuano

Kuano is a computational drug discovery company combining quantum simulation with artificial intelligence to design inhibitors against enzyme targets.

The platform models transition states during enzyme reactions, quantum mechanical events inaccessible to classical structure-based methods generating a Quantum Pharmacophore used to identify and optimise drug candidates.

The approach is designed to distinguish closely related enzyme isoforms and identify non-intuitive binding molecules, with current programmes focused on oncology.